Meropenem .

Meropenem Trihydrate, the active ingredient in Meropenem, is a carbapenem antibiotic presented as a sterile powder for reconstitution for intravenous use. It treats severe bacterial infections such as intra‑abdominal, urinary, pulmonary, bloodstream and central nervous system infections in hospitalized patients. GNH USA supplies Meropenem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem used to treat serious infections caused by Gram‑negative and Gram‑positive bacteria. It is indicated for: - Complicated intra‑abdominal infections: eradicates mixed aerobic and anaerobic pathogens in the abdominal cavity. - Complicated urinary tract infections: eliminates resistant uropathogens causing pyelonephritis and cystitis. - Nosocomial pneumonia: treats hospital‑acquired lung infections, including ventilator‑associated pneumonia. - Septicemia: provides rapid bacterial clearance in bloodstream infections. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis caused by susceptible organisms.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves without intervention. - Rash: mild skin erythema or pruritus. - Infusion site reactions: erythema or phlebitis at the injection site. - Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated colitis: severe diarrhea due to bacterial overgrowth. - Thrombocytopenia or neutropenia: marked reduction in blood cell counts. - Acute renal dysfunction: worsening kidney function in susceptible individuals.

Meropenem should be used with caution in specific clinical situations. - Renal impairment: adjust dose based on creatinine clearance to avoid accumulation. - History of seizures: monitor closely as the drug can lower seizure threshold. - Hypersensitivity: avoid in patients with known carbapenem or β‑lactam allergy. - Concomitant valproic acid therapy: may reduce antiepileptic effectiveness. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Valproic acid: may decrease seizure control when combined with meropenem. - Probenecid: can increase meropenem plasma concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Loop diuretics: may enhance renal clearance changes, necessitating dose review. - Aminoglycosides: additive nephrotoxic potential, requiring renal function monitoring. - Other β‑lactam antibiotics: possible antagonism; avoid simultaneous use unless clinically justified.